In the LEADER trial, over 9,340 patients with type 2 diabetes and high cardiovascular disease risk underwent randomization to liraglutide or placebo and were followed for a median of 3.8 years resulting in a 13% risk reduction in a combined endpoint of death from cardiovascular cause, nonfatal myocardial infarction, or nonfatal stroke [46]
Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design, Behavior and Brain Functions (2010) Lisdexamfetamine in the treatment of moderate-to-severe binge eating disorder in adults: Systematic review and exploratory meta-analysis of publicly available placebo-controlled, randomized clinical trials, Neuropsychiatric Disease and Treatment (2016) Efficacy and safety of phentermine/topiramate in adults with overweight or obesity: A systematic review and meta-analysis, Obesity (2021) Vyvanse label, DailyMed (2012) Phentermine label, DailyMed (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
But what good is oxygen if you cannot use it
Combining them might make you feel worse
In the first few weeks of treatment, your body adjusts to insulin and glucose level changes, which may explain why some people get headaches on GLP-1
Side effects are the most common reason patients hesitate before starting a GLP-1 and the most common reason they stop early
